Cryoablation is used to treat tumors in the kidney, prostate, liver, lung, breast, and soft tissue. Compared to heat-based ablation (microwave and radiofrequency), cryoablation can result in less pain, less damage to adjacent critical structures such as the renal collecting system, and better intra-procedural monitoring via visualization of the ice ball on CT, ultrasound, or MRI.
MSK investigators have created a planning tool for multiple-probe cryoablation which searches through the 5670 cryoablation simulations to find the probe spacing and ablation time that produces the desired ice ball shape and dimensions.
For academic users, please contact Franz Boas, MD, PhD, Assistant Attending, Dept. of Radiation, MSK, at firstname.lastname@example.org
For industry users, please contact Alexandra Buga, MS, MBA, Licensing Associate, Office of Technology Development, MSK, at email@example.com